Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ChromaDex Co. stock logo
CDXC
ChromaDex
$6.16
$2.31
$9.18
$611.50M2.21791,213 shs554,788 shs
Jushi Holdings Inc. stock logo
JUSHF
Jushi
$0.30
+1.2%
$0.32
$0.22
$0.69
$59.44M-0.86205,621 shs71,547 shs
MediWound Ltd. stock logo
MDWD
MediWound
$22.24
+1.3%
$17.89
$12.78
$24.00
$240.37M0.391,597 shs112,123 shs
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
$7.48
+3.0%
$6.24
$4.70
$10.44
$565.14M2.521.38 million shs1.27 million shs
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ChromaDex Co. stock logo
CDXC
ChromaDex
0.00%0.00%0.00%+43.00%+184.96%
Jushi Holdings Inc. stock logo
JUSHF
Jushi
0.00%-5.68%-24.79%+0.07%-52.07%
MediWound Ltd. stock logo
MDWD
MediWound
0.00%+8.00%+27.54%+29.34%+34.89%
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
0.00%-1.37%+3.90%+18.62%-18.18%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ChromaDex Co. stock logo
CDXC
ChromaDex
2.5164 of 5 stars
3.50.00.04.00.60.01.9
Jushi Holdings Inc. stock logo
JUSHF
Jushi
1.3825 of 5 stars
0.05.00.00.02.21.70.6
MediWound Ltd. stock logo
MDWD
MediWound
2.1136 of 5 stars
3.52.00.00.02.80.80.6
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
1.8047 of 5 stars
3.61.00.00.02.30.80.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ChromaDex Co. stock logo
CDXC
ChromaDex
3.00
Buy$9.03∞ Upside
Jushi Holdings Inc. stock logo
JUSHF
Jushi
1.50
ReduceN/AN/A
MediWound Ltd. stock logo
MDWD
MediWound
3.00
Buy$31.8042.99% Upside
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
3.25
Buy$25.11235.71% Upside

Current Analyst Ratings Breakdown

Latest JUSHF, MNMD, CDXC, and MDWD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/2/2025
MediWound Ltd. stock logo
MDWD
MediWound
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$34.00
5/22/2025
MediWound Ltd. stock logo
MDWD
MediWound
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$25.00 ➝ $31.00
5/13/2025
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/9/2025
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$20.00 ➝ $20.00
5/2/2025
MediWound Ltd. stock logo
MDWD
MediWound
Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$25.00
3/20/2025
MediWound Ltd. stock logo
MDWD
MediWound
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$25.00 ➝ $25.00
3/17/2025
ChromaDex Co. stock logo
CDXC
ChromaDex
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$11.00 ➝ $11.00
3/10/2025
ChromaDex Co. stock logo
CDXC
ChromaDex
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$8.00 ➝ $11.00
3/7/2025
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$27.00 ➝ $16.00
3/7/2025
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$55.00 ➝ $55.00
3/5/2025
ChromaDex Co. stock logo
CDXC
ChromaDex
LADENBURG THALM/SH SH
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$6.80 ➝ $8.10
(Data available from 6/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ChromaDex Co. stock logo
CDXC
ChromaDex
$99.60M0.00N/AN/A$0.38 per share0.00
Jushi Holdings Inc. stock logo
JUSHF
Jushi
$269.45M0.22N/AN/A($0.04) per share-7.56
MediWound Ltd. stock logo
MDWD
MediWound
$19.21M12.51N/AN/A$3.43 per share6.48
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
N/AN/AN/AN/A$1.90 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ChromaDex Co. stock logo
CDXC
ChromaDex
-$4.94M$0.10787.290.00N/A1.62%4.85%2.70%N/A
Jushi Holdings Inc. stock logo
JUSHF
Jushi
-$65.10M-$0.24N/AN/AN/A-20.93%N/A-10.45%8/6/2025 (Estimated)
MediWound Ltd. stock logo
MDWD
MediWound
-$6.72M-$2.09N/AN/AN/A-142.29%-82.17%-33.67%8/13/2025 (Estimated)
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
-$95.73M-$1.29N/AN/AN/AN/A-47.56%-35.55%8/12/2025 (Estimated)

Latest JUSHF, MNMD, CDXC, and MDWD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/21/2025Q1 2025
MediWound Ltd. stock logo
MDWD
MediWound
-$0.65-$0.07+$0.58-$0.07$5.20 million$3.96 million
5/8/2025Q1 2025
Jushi Holdings Inc. stock logo
JUSHF
Jushi
-$0.06-$0.09-$0.03-$0.09$66.23 million$63.85 million
5/8/2025Q1 2025
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
-$0.36-$0.35+$0.01-$0.35N/AN/A
3/19/2025Q4 2024
MediWound Ltd. stock logo
MDWD
MediWound
-$0.59-$0.36+$0.23-$0.36$5.79 million$5.84 million
3/12/2025Q4 2024
Jushi Holdings Inc. stock logo
JUSHF
Jushi
-$0.04-$0.06-$0.02-$0.06$64.03 million$65.86 million
3/6/2025Q4 2024
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
-$0.33-$0.41-$0.08-$0.41N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ChromaDex Co. stock logo
CDXC
ChromaDex
N/AN/AN/AN/AN/A
Jushi Holdings Inc. stock logo
JUSHF
Jushi
N/AN/AN/AN/AN/A
MediWound Ltd. stock logo
MDWD
MediWound
N/AN/AN/AN/AN/A
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ChromaDex Co. stock logo
CDXC
ChromaDex
N/A
2.95
2.35
Jushi Holdings Inc. stock logo
JUSHF
Jushi
N/A
1.17
0.58
MediWound Ltd. stock logo
MDWD
MediWound
N/A
2.11
1.99
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
0.09
9.00
9.00

Institutional Ownership

CompanyInstitutional Ownership
ChromaDex Co. stock logo
CDXC
ChromaDex
15.41%
Jushi Holdings Inc. stock logo
JUSHF
Jushi
21.68%
MediWound Ltd. stock logo
MDWD
MediWound
46.83%
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
27.91%

Insider Ownership

CompanyInsider Ownership
ChromaDex Co. stock logo
CDXC
ChromaDex
9.64%
Jushi Holdings Inc. stock logo
JUSHF
Jushi
22.48%
MediWound Ltd. stock logo
MDWD
MediWound
9.20%
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
2.45%
CompanyEmployeesShares OutstandingFree FloatOptionable
ChromaDex Co. stock logo
CDXC
ChromaDex
12077.75 million69.02 millionOptionable
Jushi Holdings Inc. stock logo
JUSHF
Jushi
1,188196.63 million154.04 millionNot Optionable
MediWound Ltd. stock logo
MDWD
MediWound
8010.81 million9.79 millionOptionable
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
4075.55 million71.68 millionOptionable

Recent News About These Companies

HC Wainwright Issues Pessimistic Forecast for MNMD Earnings
Cantor Fitzgerald Analysts Cut Earnings Estimates for MNMD
What is HC Wainwright's Forecast for MNMD Q1 Earnings?
MindMed Announces New Employee Inducement Grants

New MarketBeat Followers Over Time

Media Sentiment Over Time

ChromaDex stock logo

ChromaDex NASDAQ:CDXC

ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and Immulina, a spirulina extract with predominant active compounds of Braun-type lipoproteins for supporting human immune function. In addition, it offers phytochemical reference standards, and other research and development services. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation was founded in 1999 and is headquartered in Los Angeles, California.

Jushi stock logo

Jushi OTCMKTS:JUSHF

$0.30 +0.00 (+1.17%)
As of 03:58 PM Eastern

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands. It is also involved in the bulk wholesale of refined cannabinoids and terpenes. In addition, the company operates medical cannabis dispensaries under the BEYOND/HELLO, Nature's Remedy, and NuLeaf brands. It markets its products to local dispensaries and large multi-state operators. The company is headquartered in Boca Raton, Florida.

MediWound stock logo

MediWound NASDAQ:MDWD

$22.24 +0.28 (+1.28%)
Closing price 04:00 PM Eastern
Extended Trading
$22.34 +0.11 (+0.47%)
As of 05:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; and MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

Mind Medicine (MindMed) stock logo

Mind Medicine (MindMed) NASDAQ:MNMD

$7.48 +0.22 (+3.03%)
Closing price 04:00 PM Eastern
Extended Trading
$7.39 -0.09 (-1.20%)
As of 05:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.